CAR-NK cell therapy for hematologic malignancies: advances, challenges and optimization strategies.

Liu W, Miao H, Weng L, Cao X

Open source

DOI
10.1186/s12943-026-02648-z
Published
2026 Mar 26
Container
Molecular cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12943-026-02648-z,
  title = {CAR-NK cell therapy for hematologic malignancies: advances, challenges and optimization strategies.},
  author = {Liu W and Miao H and Weng L and Cao X},
  year = {2026},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-026-02648-z},
  url = {https://doi.org/10.1186/s12943-026-02648-z}
}

RIS

TY  - JOUR
TI  - CAR-NK cell therapy for hematologic malignancies: advances, challenges and optimization strategies.
AU  - Liu W
AU  - Miao H
AU  - Weng L
AU  - Cao X
PY  - 2026
JO  - Molecular cancer
DO  - 10.1186/s12943-026-02648-z
UR  - https://doi.org/10.1186/s12943-026-02648-z
ER  - 

APA

W, L., H, M., L, W., & X, C. (2026). CAR-NK cell therapy for hematologic malignancies: advances, challenges and optimization strategies.. Molecular cancer. https://doi.org/10.1186/s12943-026-02648-z

Source records